PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MiCAN Technologies Inc., KKVP 1-36, Goryo-ohara, Nishikyo-Ku, Kyoto, 615-8245, Japan.\', \'Department of Viral Infection, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-oka, Suita, Osaka, 565-0871, Japan.\', \'Faculty of Tropical Medicine, Mahidol-Osaka Center for Infectious Diseases, Mahidol University, Bangkok, Thailand.\', \'MiCAN Technologies Inc., KKVP 1-36, Goryo-ohara, Nishikyo-Ku, Kyoto, 615-8245, Japan. kmiyazaki@micantechnologies.com.\', \'Department of Viral Infection, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-oka, Suita, Osaka, 565-0871, Japan. shioda@biken.osaka-u.ac.jp.\', \'Faculty of Tropical Medicine, Mahidol-Osaka Center for Infectious Diseases, Mahidol University, Bangkok, Thailand. shioda@biken.osaka-u.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-03273-0
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34887501
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • The potential of COVID-19 patients\' sera to cause antibody-dependent enhancement of infection and IL-6 production.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all